Comparison of curative effects of amisulpride and risperidone in the treatment of patients with first-episode schizophrenia
10.3760/cma.j.issn.1008-6706.2017.14.032
- VernacularTitle:氨磺必利与利培酮治疗首发精神分裂症的疗效比较
- Author:
Hongfeng FAN
;
Lijing JU
;
Qifeng DU
;
Jing HU
;
Xinwei HU
;
Zhizhen PENG
- Keywords:
Schizophrenia;
Amisulpride;
Risperidone
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(14):2199-2202
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of amisulpride and risperidone in the treatment of patients with first-episode schizophrenia and its influence on social function.Methods 70 patients of schizophrenia conformed to the International classification of diseases tenth edition(ICD-10) were randomly divided into amisulpride group(observation group,35 cases) and risperidone group(control group,35 cases) by using the random number table method.The Positive and Negative Scale(PANSS) was used to evaluate the efficacy,the Scale of Social Function in Psychosis Inpatients(SSPI) was used to evaluate social function before and after 8 weeks of treatment.Results After 8 weeks treatment,the negative symptom factor score of the PANSS in the observation group was (15.04±3.55)points,which was improved significantly compared with (17.82±3.87)points in the control group,the difference was statistically significant(t=3.132,P<0.05).The scores of the field in movement and interaction,social activities and skills factor score and the total score of SSPI in the observation group were (15.49±3.54)points,(14.53±4.25)points,(39.25±8.27)points,respectively,which in the control group were (12.78±3.29)points,(10.01±3.78)points,(33.72±7.83)points,respectively,the differences between the two groups were statistically significant (t=3.317,4.701,2.873,all P<0.05).Conclusion Amisulpride is effective in improving the negative symptoms,social function in patients with schizophrenia,and the effect is better than risperidone.
